Prevention of breast cancer using rexinoids: results of a phase II biomarker modulation trial using bexarotene in women at high risk of breast cancer.

被引：0
|
作者：
Brown, P. [1 ,2 ,3 ,4 ,5 ,6 ]
Arun, B. [1 ,2 ,3 ,4 ,5 ,6 ]
Miller, A. [1 ,2 ,3 ,4 ,5 ,6 ]
Isaacs, C. [1 ,2 ,3 ,4 ,5 ,6 ]
Gutierrez, C. [1 ,2 ,3 ,4 ,5 ,6 ]
Huang, J. [1 ,2 ,3 ,4 ,5 ,6 ]
Mohsin, S. [1 ,2 ,3 ,4 ,5 ,6 ]
Sneige, N. [1 ,2 ,3 ,4 ,5 ,6 ]
Kim, H. [1 ,2 ,3 ,4 ,5 ,6 ]
Sexton, K. [1 ,2 ,3 ,4 ,5 ,6 ]
Weiss, H. [1 ,2 ,3 ,4 ,5 ,6 ]
Hilsenbeck, S. [1 ,2 ,3 ,4 ,5 ,6 ]
Lamph, W. [1 ,2 ,3 ,4 ,5 ,6 ]
Negro-Vilar, A. [1 ,2 ,3 ,4 ,5 ,6 ]
Johnson, K. [1 ,2 ,3 ,4 ,5 ,6 ]
Elledge, R. [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] MD Anderson Canc Ctr, Houston, TX USA
[3] Canc Therapy & Res Ctr S Texas, San Antonio, TX 78229 USA
[4] Georgetown Univ, Washington, DC USA
[5] Ligand Pharmaceut, San Diego, CA USA
[6] Natl Canc Inst, Bethesda, MD USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S181 / S182
页数：2
相关论文
共 50 条
  • [1] Acquisition of breast tissue in a biomarker modulation study using bexarotene in women at high risk of breast cancer.
    Arun, B
    Mohsin, S
    Miller, A
    Isaacs, C
    Saxton, K
    Hilsenbeck, S
    Lamph, W
    Johnson, K
    Brown, P
    Elledge, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 106S - 106S
  • [2] Phase II biomarker prevention trial of celecoxib vs. placebo in women at high risk for development of breast cancer.
    Fabian, Carol
    Kimler, Bruce
    Mayo, Matthew
    Zalles, Carola
    CANCER RESEARCH, 2008, 68 (09)
  • [3] Phase II tissue-based biomarker prevention trial of celecoxib in premenopausal women at high risk for development of breast cancer.
    Fabian, C. J.
    Kimler, B. F.
    Mayo, M. S.
    Zalles, C. H.
    Khan, S. A.
    Dooley, W. C.
    Krontiras, H.
    Browne, D.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S179 - S179
  • [4] Phase II prevention trial of celecoxib in women at increased risk for breast cancer
    Arun, B.
    Logan, C.
    Yin, G.
    Yun, G.
    Hortobagyi, G. G.
    Browne, D.
    Sneige, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Phase II breast cancer chemoprevention study with celecoxib in women at increased risk for breast cancer.
    Arun, B.
    Valero, V.
    Yin, G.
    Babiera, G.
    Murray, J. L.
    Browne, D.
    Gong, Y.
    Cook, E.
    Hortobagyi, G. N.
    Sneige, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 51S - 51S
  • [6] A Randomized Phase II Biomarker Study of Atorvastatin in Premenopausal Women at Increased Risk for Breast Cancer.
    Wood, M. E.
    Kingsley, F.
    Ellerton, J. A.
    Atkins, J. N.
    Grubs, S. S.
    Muss, H. B.
    Garber, J. E.
    CANCER RESEARCH, 2011, 71
  • [7] Breast cancer prevention using anastrozole in postmenopausal women at high risk
    Cuzick, J.
    Sestak, I.
    Forbes, J. F.
    Dowsett, M.
    Knox, J.
    Cawthorn, S.
    Saunders, C.
    Roche, N.
    Mansel, R. E.
    von Minckwitz, G.
    Bonanni, B.
    Palva, T.
    Howell, A.
    CANCER RESEARCH, 2013, 73
  • [8] Short breast MRI screening trial in women at high-risk for breast cancer.
    Scoggins, Marion
    Dogan, Basak
    Ma, Jingfei
    Wei, Wei
    Song, Jong Bum
    Candelaria, Rosalind P.
    Litton, Jennifer Keating
    Arun, Banu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Management of women at high risk for breast cancer.
    Costa, A
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1254S - 1255S
  • [10] Breast MRI surveillance in women at high risk for breast cancer.
    Bradbury, AR
    Newstead, G
    Li, LS
    Arkani, S
    Abe, H
    Cummings, S
    Olopade, OI
    Chicago, IL
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S151 - S151
12345